146.950
146.95 (0%)
As of Dec 24, 2024
Repligen Corp [RGEN]
Source:
Company Overview
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs.
Country | United States |
Headquarters | waltham |
Phone Number | 7814499560 |
Industry | manufacturing |
CEO | Tony J. Hunt |
Website | www.repligen.com |